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a  b  s  t  r  a  c  t
Population  epidemiological  models  where  hosts  can  be infected  sequentially  by  different  strains  have
the potential  to help  us  understand  many  important  diseases.  Researchers  have  in recent  years  started
to  develop  and use  such  models,  but the  extra  layer  of complexity  from  multiple  strains  brings  with  it
many  technical  challenges.  It is  therefore  hard  to build  models  which  have  realistic  assumptions  yet  are
tractable.  Here  we  outline  some  of  the  main  challenges  in this area. First  we begin  with  the fundamen-
tal  question  of  how  to translate  from  complex  small-scale  dynamics  within  a  host  to  useful  population
models.  Next  we  consider  the  nature  of so-called  “strain  space”.  We  describe  two  key  types  of host  het-
erogeneities,  and  explain  how  models  could  help  generate  a better  understanding  of  their  effects.  Finally,
for  diseases  with  many  strains,  we  consider  the challenge  of  modelling  how  immunity  accumulates  over
multiple  exposures.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Mathematical models of “fully immunising” infections like
measles have become useful tools for understanding the dynamics
of some infections and, in several instances, planning their con-
trol. However, there are many common and important infections
that simply do not follow the assumptions of “measles models”.
For examples measles models fail to illuminate the behaviour of
pathogens that exist as inter-related families of strains or variants.
Inﬂuenza, norovirus, malaria and dengue virus are just a few of the
infectious agents for which the interacting dynamics of different
strains form a crucial part of their biology.
Recent decades have seen substantial progress in building a
stronger understanding of how partial host immunity acts to struc-
ture the population dynamics of such infections. However, much
remains to be done. In this review we lay out ﬁve challenge areas
that we believe remain open and important for advancing our
understanding of strain dynamics.
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1. Translating from single host to population strain models
To make tractable population models of multiple strains,
modellers typically make relatively simple assumptions about
the nature of “partial cross-immunity”. For example, a partially
immune host can be treated as having a lower rate of becoming
infected (reduced susceptibility) or a lower rate of transmitting
the infection to others (reduced transmissibility), but reality for
some systems may  be a mix  of the two, and also other effects
such as reduced duration of infection (Park et al., 2009). A major
challenge for the area, and indeed one that underpins all the
other challenges presented here, is how to choose an appropri-
ate abstraction: for a given system, how should we move from
the full immunodynamics at the individual host level to reason-
able assumptions that can be incorporated into population models?
We explore some aspects of these choices and their consequences
here.
If we deﬁne ‘reduction in host susceptibility’ as a reduction in
the probability that an infection can take place within an individ-
ual host, then if an infection does indeed occur does it proceed
as normal, or not? If the infection does not proceed, is that indi-
vidual then also protected in subsequent challenges? On the other
hand, deﬁning ‘reduction in host infectiousness’ as a reduction in
the probability of onward transmission, does this occur because the
http://dx.doi.org/10.1016/j.epidem.2014.07.005
1755-4365/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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peak in pathogen load is generally diminished, and/or is there sim-
ply faster clearance of pathogen following that peak? Further, is it
the overall pathogen load that matters, or only the pathogen load
in particular tissues, and how do these different factors combine to
favour certain pathogen strains?
The rate of pathogen clearance, or the duration of infectiousness,
is affected by partial immunity, and this will consequently shape
both the pathogen population that is available for onward trans-
mission. In particular, the immune system is designed to rapidly
recall pre-existing cross-reactive immune responses from mem-
ory and any such responses therefore have a selective advantage
over novel immune responses within infected hosts. The repertoire
of partial immunity within an individual host might not there-
fore change much as a result of an exposure in which little if any
pathogen replication takes place, but if the host, in effect, ignores
some of the antigenic novelties of this particular pathogen then this
may  be to the pathogen’s long-term advantage. Equally, recalled
responses may  result in a poorer quality response than that seen
in naïve individuals in some circumstances – see original antigenic
sin (Kucharski and Gog, 2012a; Haaheim, 2002) – and/or result in
immunopathogenesis (Ubol and Halstead, 2010).
A careful consideration of what immune escape means at the
level of a single host may  also help us develop more informative
models of pathogen evolution at the population level. If each muta-
tion makes only a subtle change to the antigenic proﬁle of the
pathogen, how do such novel variants overcome their inevitable
disadvantage in frequency compared to the wildtype within a host?
On the other hand, if each mutation makes a sufﬁciently large
change to the antigenic proﬁle of the pathogen so that it totally
escapes from pre-existing responses, does this not then drastically
affect the subsequent proﬁle of pathogen load within these indi-
viduals? In attempting to answer these sorts of questions, recent
work on the inﬂuenza virus neatly illustrates alternative mecha-
nisms of escape: viruses that bind to target cells faster – giving the
immune system less time to eliminate them – may  be favoured in
the presence of a strong immune response (Hensley et al., 2009;
Yuan and Koelle, 2013). Simultaneous infection by different vari-
ants of the same pathogen may  also affect the possibilities and
propensities for antigenic change (see [reference] paper in this vol-
ume.)
We must consider how the various arms of the immune
response act both in concert and independently to moderate the
extent of infection and the types of selection that they impose
on a within host level and how this then manifests at the level
of host populations. In the case of viruses for example, at the
most basic level, antibody responses can act to eliminate cell-free
virus, whereas CD8+ T cells destroy infected cells. Thus, the lat-
ter response only comes into play once infection is underway but
an antiviral antibody response has the chance to terminate an
infection before any replication takes place. Meanwhile, the role
of innate immunity in regulating pathogen load has often been
ignored since it would be expected to target strains indiscrimi-
nately. Nevertheless, this is not necessarily the case: elements of
the innate immune system have now been shown to behave in an
adaptive manner (Vivier et al., 2011). Each type of response may
therefore act in different ways to suppress pathogen replication
(i.e. exert different selection pressures), not to mention that each
tends to target fundamentally different antigens, and therefore ulti-
mately differentially affect pathogen evolution.
Without a better understanding of the above, it will be difﬁcult
to build models that explicitly link within to between host dynam-
ics. Nevertheless, provided comprehensive within-host infectious
datasets are available, a recent approach sidesteps this problem by
estimating genetic covariance functions for the pathogen traits of
interest (Day et al., 2011; Mideo et al., 2011). Not only does this yield
interesting insights, for example into the interplay between the age
distribution of infections and the genetic constraints imposed on
the pathogen, but it should also ultimately complement and help
validate future developments in our understanding of mechanistic
within-host processes.
2. The nature of strain space
A critical issue in modelling multi-strain systems is how to
best represent the relationships between the biological entities
involved. A common approach is to consider strain space as a con-
tinuous volume, surface or even, most simply, a single dimension
in which the Euclidean distance between points serves as a mea-
sure of their antigenic and/or genetic similarity (Lin et al., 1999,
2003; Gog and Swinton, 2002; Bedford et al., 2012). This approach is
appropriate when the targets of immunity (or epitopes) can expe-
rience continuous variation, and also substitute for each other in
the sense that strong immunity against one epitope can compen-
sate for a lack of immunity against another. Alternatively, one can
argue that antigenic distance should be regarded as the minimum
distance across all dimensions (Kryazhimskiy et al., 2007). In both
cases, an implicit assumption is that antigenic space is homoge-
nous.
Variation in epitopes can also be considered as discrete, with
strains occupying nodes {i,j,k,. . .}  where i designates a particular
variant of epitope 1, j designates a particular variant of epitope 2,
etc. As with continuous systems, a function has to be chosen to
express the risk of infection with (or transmission of) a strain in
relation to the fraction of epitopes previously encountered. This
could simply be proportional to the Hamming distance between
two strains or epitope strings, or take some more complex form
(e.g. Zinder et al., 2013). In Gupta et al. (1998), for example, expo-
sure to any fraction of epitopes is sufﬁcient to reduce transmission
by (1 − ) where  represents the strength of immune selection
(Gupta et al., 1998). An alternative formulation was explored in
Recker et al., where risk of re-infection was zero when the frac-
tion of epitopes already encountered was 1 even though the exact
strain may  not have been encountered previously; however it was
only possible to write down a set of equations for a 2-locus, 2-allele
system (Recker et al., 2007). Much further work needs to be done
to link particular behaviours to different functional forms in both
discrete and continuous systems.
An important challenge is to identify which of these struc-
tures adequately represents the “strain space” of a particular
host–pathogen system as this affects the dynamics in important
ways. Many of these systems exhibit polarisation (i.e. discrete strain
structure) but not all will exhibit cyclical and/or chaotic behaviour
(Gomes et al., 2002). The mode and tempo of mutation (i.e. the
rate of generation of novel antigenic types) can also be important
(Zinder et al., 2013; Bedford et al., 2012; Minayev and Ferguson,
2009). One would hope that a combination of molecular and sero-
logical studies should enable us to assign the most appropriate
structure to each system, but this may  not be easy. For example,
antibodies typically target conformational epitopes on the surface
of pathogens. As such, mutations within the epitope itself may com-
pletely, subtly or not at all change its biochemical properties, or
mutations outside the epitope may  nevertheless affect the pre-
sentation of the epitope and the strength of antibody binding. In
other words, there is not necessarily a clear mapping from geno-
type to antigenic phenotype and multiple substantially different
genotypes may  correspond to identical phenotypes, whilst other
closely related genotypes may  quite far apart in phenotypic space.
These concepts form the basis of ‘neutral network’ theories of strain
space (Koelle et al., 2006) but many problems remain when trying
to match the increasingly available genetic data to model driven
hypotheses of antigenic evolution.
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3. Host heterogeneity: population structure
When population heterogeneity is incorporated into trans-
mission models, it has the potential to substantially change the
dynamics of an infection. Certain types of heterogeneity are rela-
tively straightforward to add to strain models. It has been observed
that strain diversity can increase if contact network (Buckee et al.,
2004) or community structure (Buckee et al., 2007) is included in
a simple multi-strain model. Further, variation in social contacts
between different age groups can inﬂuence the interaction between
epidemic dynamics and population-level immunity after multiple
infections (Kucharski and Gog, 2012a).
Other kinds of heterogeneity are more challenging to incorpo-
rate into models. To ensure computational tractability, many strain
models do not track all possible combinations of past infections;
instead they gather these combinations into summary variables.
These summary variables are used to capture the immune state
of the population (Gog and Swinton, 2002; Gupta et al., 1998;
Kucharski and Gog, 2012b) with the potential for substantial
generalizations (Ferguson and Andreasen, 2002). To make this
simpliﬁcation possible, models assume a population without immi-
gration: other than via births or deaths, nobody enters or leaves the
pool of potential hosts. However, the simpliﬁed model structure
breaks down when models include movement of people, rather
than just transmission of infection between locations or social
groups. If new individuals arrive or leave, the values of the sum-
mary variables – which were tailored to the original population –
no longer reﬂect the true level of population immunity.
A key challenge is to understand how population structure and
movement inﬂuences strain dynamics over long timescales. In par-
ticular, it is important to ﬁnd ways to extend population models
of disease strains to account for changes in host demograph-
ics, such as individual movements between different locations
or ﬂuctuations in birth rate. These changes could have a major
impact on the immune composition of the host population, and
hence the evolutionary dynamics of an infection. A surplus of
partially immune hosts could increase selection pressure exerted
on a pathogen, and inﬂuence the proliferation of new antigenic
variants.
Individual-based models could be used to examine how hetero-
geneities interact with strain dynamics in this manner. Such models
would make it possible to explore the effects of population het-
erogeneity on pathogen competition and the appearance of new
strains (Ferguson et al., 2003). For example, there is the potential
to examine how changes in population structure have inﬂuenced
the emergence and re-emergence of inﬂuenza and dengue fever
subtypes in the past. Multi-strain models could also show how spa-
tial movements might combine with strain interactions to affect
disease incidence.
4. Host heterogeneity: variation in immune response
Until now our discussion has focussed on the heterogeneity that
is associated with the hosts’ position in the transmission network,
and their previous exposures to related strains. This approach to
cross-immunity implies that hosts are identical in their immune
response in the sense that if two hosts were exposed to exactly
the same sequence of challenges during their lives, then they
would mount the same immune response – at least in a prob-
abilistic sense. There is, however, ample evidence that variation
in immune type, nutritional status, and age may  affect the speci-
ﬁcity of the immune response. For example while children produce
a monoclonal response to inﬂuenza infection older individuals
produce polyclonal responses (Cobey and Pascual, 2011). Further-
more, certain hosts may  respond to conserved epitopes while
others recognise variable epitopes (Gupta and Galvani, 1999). Host
immune responses also suffer restriction by the Major Histocom-
patibility Complex, and modelling this interface between host and
pathogen (Penman et al., 2013; Fryer et al., 2010) remains a key
challenge.
Host speciﬁcity of the cross-immunity response may  be hard to
identify even in challenge experiments. For example imagine that
we have a population that had all been previously infected with
strain A. When challenged with a related strain B, we observe that
40% of the hosts become infected. We  may  then conclude either
that each individual host has a 40% chance of being reinfected when
challenged (and that this is a random effect at point of challenge) or
that 40% of the host population will be reinfected when challenged
(and that these individuals are predetermined by some inherent
variability). Most multi-strain studies assume the former of these
interpretations (but see (Cobey and Pascual, 2011; Simpson and
Roberts, 2012)) and it is currently unclear how inherent hetero-
geneities in immune response affect disease transmission.
5. Accumulation of immunity from multiple strains
Suppose we  have a deﬁned strain space, and we know how expo-
sure to one strain confers partial immunity to another strain. With
three or more strains we  would still be left with an ambiguity about
how immunity from multiple exposures accumulates. For example,
suppose strain A reduces susceptibility to strain C by a factor 0.5,
and strain B reduces susceptibility to strain C by a factor 0.6. How
immune to strain C is someone who  has had both strains A and
B? To put the problem in mathematical terms, we require a func-
tion that depends on the set of strains previously seen (Andreasen
et al., 1997), which somehow we must specify or extend from the
function evaluated for each strain singly. Generally modellers have
selected their model for convenience, or indeed without comment
about how immunity accumulates: this aspect of model choice
often goes uncommented on and therefore perhaps unnoticed, but
has potential to alter the dynamics of a strain model.
One extreme adopted by many modellers is so-called “product”
cross-immunity (Gog and Grenfell, 2002), where the factors reduc-
ing susceptibility or transmissibility accumulate geometrically: the
reduction is therefore 0.3 in the above example. Another extreme
is “minimum” cross-immunity, where essentially the strain (or
one of the strains) that confers the strongest immunity is the
one that is counted. In the above example, it means that the 0.5
reduction from strain B counts, and strain C “sees” no difference
between those previously infected by B, and those infected by both
B and A. The minimum and product each can offer mathemati-
cal convenience, but how valuable that is depends on the model
framework. Minimum cross-immunity means that potentially only
a small amount of information is needed per host, for example
with a linear strain space for annual inﬂuenza: for each host only
their most recent strain infection shapes their immune response to
newer strains (Andreasen, 2003). The product assumption means
that all past exposures contribute to the current immunity, but
sometimes the product gives some mathematical independence
that can be used to simplify the model variables (Gog and Swinton,
2002).
Epitope models (see ‘nature of strain space’) are neither of the
above: their structure is more complex, but based on consider-
ation of how immunity may depend on contributions from multiple
“parts” of the pathogen. Epitope models can sidestep the issue
of how immunity accumulates, as cross immunity is no longer a
function of a set of strains seen, but rather a set of epitopes seen.
However, if our epitope space is ﬁne enough that there are similar
epitopes, we will be back with the same questions.
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There are three aspects to this challenge that would enhance our
ability to model infectious diseases. Firstly there is the mathemati-
cal challenge to characterise exactly what the effects of different
assumptions about how immunity accumulates are. When does
it not matter which we choose, and when would the dynamics
depend on choice? Some progress has been made in comparing the
different modelling assumptions (Dawes and Gog, 2002; Gomes
et al., 2002) but so far these have been speciﬁc to certain sim-
ple strain spaces. The second aspect is to develop frameworks
that allow relatively simple models to be developed with broader
assumptions possible than now, so that we are not constrained to
one choice for tractability (Kucharski and Gog, 2012a,b). The third
and perhaps most urgent part is that we need a better empirical
understanding of how partial immunity accumulates for different
pathogens and hosts. This comes back to the challenge of translating
from within-host dynamics to tractable population models.
Summary
All models – be they mathematical, animal or experimental – are
a necessary abstraction of reality. We  use models precisely because
we cannot hope to recreate the system in full either for practical
or ethical reasons. The challenges we present here involve under-
standing how such abstractions affect disease dynamics, with the
aim of using models to identify the critical determinants driving
the system’s behaviour.
Model validation is central to such work. This includes an assess-
ment of the individual building blocks of the model and an analysis
the overall model behaviour: are the underlying biological assump-
tions plausible, and does the model capture the system it is trying
to emulate? As different models can lead to the same behaviour,
the generation of testable inferences that allow discrimination
between models is crucial. Validation may  take the form of qualita-
tive comparisons, with the model behaving in a dynamically similar
way to the real system, or quantitative inference, whereby spe-
ciﬁc model outputs are compared with empirical measurements in
statistical framework.
It may  be the case that a model can reproduce observed dynam-
ics despite omitting a known biological phenomenon. This does
not mean that the model is invalid; rather, it may  indicate that this
particular phenomenon is not as important as was initially sup-
posed (i.e. it does not radically affect the behaviour of the model).
However, we cannot know this until we have made comparisons
between models that both include and exclude the phenomenon of
interest.
The intention of this review is to highlight phenomena that have
been little studied to date, and outline potential comparisons that
could be made between different biological assumptions. When
incorporated into appropriate models, these features may  provide
useful insight into the biology of both pathogens that exist as mul-
tiple strains and their target hosts. Some of these challenges may
prove more difﬁcult than others, but each represents a new and
exciting frontier for future research.
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